Tag: GCP compliance

Contractual Language That Clearly Allocates GCP Responsibilities

Posted on By digi

Contractual Language That Clearly Allocates GCP Responsibilities Contractual Language That Clearly Allocates GCP Responsibilities In the complex realm of clinical trials, particularly in the context of Good Clinical Practice (GCP), the clarity of contractual language is paramount. This article serves as a step-by-step tutorial for clinical operations, regulatory affairs, and medical affairs professionals in the…

Read More “Contractual Language That Clearly Allocates GCP Responsibilities” »

Sponsor & CRO GCP Obligations

Dynamic Risk Assessment: Updating Profiles With New Signals and Data

Posted on By digi

Dynamic Risk Assessment: Updating Profiles With New Signals and Data Dynamic Risk Assessment: Updating Profiles With New Signals and Data Understanding Dynamic Risk Assessment in Clinical Trials Dynamic risk assessment is an essential practice within the realm of clinical trials, allowing for the continuous evaluation of risks throughout the trial process. It enables researchers and…

Read More “Dynamic Risk Assessment: Updating Profiles With New Signals and Data” »

Risk Assessment & Risk Controls

Source Templates, Note-To-File Use and Common Audit Findings

Posted on By digi

Source Templates, Note-To-File Use and Common Audit Findings Source Templates, Note-To-File Use and Common Audit Findings Introduction to Source Documentation in Clinical Trials Source documentation is a critical aspect of clinical trials that ensures the integrity and credibility of trial data. This documentation serves as the foundation upon which data submitted to regulatory authorities is…

Read More “Source Templates, Note-To-File Use and Common Audit Findings” »

Visit Management & Source Documentation

Nursing and Coordinator Workflows for Efficient Visit Execution

Posted on By digi

Nursing and Coordinator Workflows for Efficient Visit Execution Nursing and Coordinator Workflows for Efficient Visit Execution Understanding Visit Execution in Clinical Trials Efficient visit execution is a cornerstone of successful clinical trials, especially when leveraging real world data clinical trials for comprehensive outcomes. This guide elaborates on how nursing and research coordinators can navigate visit…

Read More “Nursing and Coordinator Workflows for Efficient Visit Execution” »

Visit Management & Source Documentation

Oversight of Monitoring, Data Management and Statistical Functions Under GCP

Posted on By digi

Oversight of Monitoring, Data Management and Statistical Functions Under GCP Oversight of Monitoring, Data Management and Statistical Functions Under GCP Good Clinical Practice (GCP) guidelines set forth by regulatory authorities such as the FDA, EMA, and MHRA outline the necessary requirements for the conduct of clinical trials. This tutorial serves as a comprehensive guide focused…

Read More “Oversight of Monitoring, Data Management and Statistical Functions Under GCP” »

Sponsor & CRO GCP Obligations

Sponsor Responsibilities in Decentralized and Platform Trial Models

Posted on By digi

Sponsor Responsibilities in Decentralized and Platform Trial Models Sponsor Responsibilities in Decentralized and Platform Trial Models Introduction to Decentralized and Platform Trials In the evolving landscape of clinical research, decentralized and platform trial models have gained prominence, offering opportunities to enhance patient engagement, improve efficiency, and broaden the scope of data collection. These novel methodologies…

Read More “Sponsor Responsibilities in Decentralized and Platform Trial Models” »

Sponsor & CRO GCP Obligations

Designing Risk Controls for Safety, Data Integrity and Participant Protection

Posted on By digi

Designing Risk Controls for Safety, Data Integrity and Participant Protection Designing Risk Controls for Safety, Data Integrity and Participant Protection The design and execution of clinical trials are foundational procedures that ensure the safety of participants and the integrity of data collected. This step-by-step tutorial provides a comprehensive framework for clinical operations, regulatory affairs, and…

Read More “Designing Risk Controls for Safety, Data Integrity and Participant Protection” »

Risk Assessment & Risk Controls

Handling Missed, Rescheduled and Out-of-Window Visits Without Chaos

Posted on By digi

Handling Missed, Rescheduled and Out-of-Window Visits Without Chaos Handling Missed, Rescheduled and Out-of-Window Visits Without Chaos In the realm of real world evidence clinical trials, effectively managing patient visits is crucial for data integrity and regulatory compliance. Missed, rescheduled, or out-of-window visits can introduce complexities that compromise the quality and reliability of collected data. This…

Read More “Handling Missed, Rescheduled and Out-of-Window Visits Without Chaos” »

Visit Management & Source Documentation

Paper vs Electronic Source: Choosing Systems and Managing Transitions

Posted on By digi

Paper vs Electronic Source: Choosing Systems and Managing Transitions In the modern landscape of clinical trials, particularly in fields such as Crohn’s disease clinical trials and ulcerative colitis clinical trials, the debate between paper and electronic source documentation remains a critical discussion point for clinical operations, regulatory affairs, and medical affairs professionals. This tutorial aims…

Read More “Paper vs Electronic Source: Choosing Systems and Managing Transitions” »

Visit Management & Source Documentation

Risk-Based Quality Management Systems for Sponsors and CROs

Posted on By digi

Risk-Based Quality Management Systems for Sponsors and CROs In the realm of clinical trials, particularly in contexts such as non-small cell lung cancer clinical trials, the implementation of a Risk-Based Quality Management System (RBQM) is essential for ensuring compliance and enhancing the quality of research. This guide provides a comprehensive overview of RBQM systems for…

Read More “Risk-Based Quality Management Systems for Sponsors and CROs” »

Sponsor & CRO GCP Obligations